Feng-rui Li

Secretogranin III upregulation is involved in parkinsonian toxin-mediated astroglia activation.

H. Pang, E. Jiang, Feng-rui Li, 2020, The Journal of toxicological sciences.

Effects of PQ's cytotoxicity on secretory vesicles in astroglia: Expression alternation of secretogranin II and its potential interaction with intracellular factors.

H. Pang, Xiaoni Zhan, Qiaohong Chu, 2018, Biochemical and biophysical research communications.

Screening of polymorphisms located in the FGF20 and TMEM175 genes in North Chinese Parkinson's disease patients.

Y. Ren, Feng-rui Li, Jing Cc, 2015, Genetics and molecular research : GMR.

High‐Resolution Melting Analysis as a Developed Method for Genotyping the PD Susceptibility Loci in LRRK2 Gene

H. Pang, Bao-jie Wang, E. Jiang, 2015, Journal of clinical laboratory analysis.

Clathrin-Dependent Uptake of Paraquat into SH-SY5Y Cells and Its Internalization into Different Subcellular Compartments

H. Pang, Bao-jie Wang, Feng-rui Li, 2017, Neurotoxicity Research.

Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population

Xiaoguang Luo, H. Pang, Yan Ren, 2012, Journal of Clinical Neuroscience.

Dysregulated expression of secretogranin III is involved in neurotoxin‐induced dopaminergic neuron apoptosis

H. Pang, Bao-jie Wang, Feng-rui Li, 2012, Journal of neuroscience research.

Lack of association between three single nucleotide polymorphisms in the PARK9, PARK15, and BST1 genes and Parkinson's disease in the northern Han Chinese population.

Xiao-Guang Luo, H. Pang, Yan Ren, 2012, Chinese medical journal.